 |
 |
|
10th Circuit Reverses Nutraceutical Ruling
|
| DENVER -- A 10th Circuit U.S. Court of Appeals panel on Aug. 17 reversed and remanded the 2005 summary judgment ruling by U.S. Judge Tena Campbell of the District of Utah, who found that the Food and Drug Administration's use of a risk-benefit analysis in its final rule banning the sale of ephedra products was contrary to congressional intent (Nutraceutical Corp., et al v. Andrew Von Eschenbach, et al., No. 05-4151, 10th Cir.; 2006 U.S. App. LEXIS 21066). |
|
|
 |
|
|
